For research use only
| Cat No. | ABC-X0041C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocyte |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The NRAS (G12A) BAF3 cell line provides you with a customized tumor research model, aiding drug testing and mechanism understanding to meet your research.
Human NRAS (G12A) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. NRAS (G12A) BAF3 mutant cell line is generated by stable integration of exogenous human NRAS gene harboring the G12A mutation into Ba/F3 host cells using our optimized transduction of lentiviral vectors.
Target
NRAS is a small GTPase that regulates signal transduction through the MAPK and PI3K pathways. The G12A mutation impairs GTP hydrolysis and maintains NRAS in an active, GTP-bound state, contributing to constitutive downstream signaling and oncogenesis. This mutation is recurrent in melanoma and hematologic malignancies. AcceGen offers custom-engineered mutant cell models tailored for functional studies and drug testing. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0041C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocyte |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The NRAS (G12A) BAF3 Cell Line enables exploration of NRAS-driven oncogenic pathways, evaluation of RAS pathway inhibitors, and study of IL-3-independent proliferation. It supports drug discovery, mutation-specific research, and mechanistic understanding of NRAS-related cancers.